Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial.

A, Mangia; N, Minerva; D, Bacca; R, Cozzolongo; GL, Ricci; V, Carretta; F, Vinelli; G, Scotto; G, Montalto; M, Romano; G, Cristofaro; L, Mottola; F, Spirito; A, Andriulli

doi:10.1002/hep.22061

Public

Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial.

Shared by NobleBlocks on Jan 1, 2008 • 12:00 AM UTC

Authors:

Mangia A

Minerva N

Bacca D

Abstract

<h4>Unlabelled</h4>It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n = 696) received peginterferon alfa-2a, 180 mg/week, or peginterferon alfa-2b...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!